Immunovia, a blood-based diagnostic company, has named Jeff Borcherding as global CEO. Borcherding, until now president of the firm’s US operations replaces current CEO, Philipp Matthieu. The move marks the…
Immunovia, a blood-based diagnostic company, has named Jeff Borcherding as global CEO. Borcherding, until now president of the firm’s US operations replaces current CEO, Philipp Matthieu. The move marks the…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


